JW Lifescience Corporation (KRX:234080)
11,120
+30 (0.27%)
At close: Apr 17, 2025, 3:30 PM KST
JW Lifescience Revenue
In the year 2024, JW Lifescience had annual revenue of 222.48B KRW with 7.55% growth. JW Lifescience had revenue of 54.79B in the quarter ending December 31, 2024, with 2.16% growth.
Revenue
222.48B
Revenue Growth
+7.55%
P/S Ratio
0.78
Revenue / Employee
739.13M
Employees
301
Market Cap
173.74B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 222.48B | 15.62B | 7.55% |
Dec 31, 2023 | 206.86B | 17.93B | 9.49% |
Dec 31, 2022 | 188.93B | 19.11B | 11.26% |
Dec 31, 2021 | 169.82B | -13.70B | -7.47% |
Dec 31, 2020 | 183.52B | 13.30B | 7.81% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 68.13B |
Peptron | 3.15B |
LigaChem Biosciences | 125.90B |